Otezla 30 MG tablet 60S
Ended Awarded Last action
- Contract number
- SPE2DR26FJ5D5
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,442
Award facts
- Contract value 100% obligated
- $13,442.21 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $13,442.21 to AmerisourceBergen Drug Corp for the supply of Otezla 30 mg tablets (60-count units) on January 13, 2026, with an ultimate completion date of January 14, 2026. This non-set-aside, competitively awarded contract utilizes firm fixed-price pricing and is being fulfilled from the vendor's location in Conshohocken, Pennsylvania. The delivery order represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031, which serves as the comprehensive vehicle for supplying pharmaceutical products and medical supplies to military healthcare programs globally.
AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., functions as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems. The parent company's substantial IDC with DLA encompasses a broad range of medical commodities including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. This specific delivery order for Otezla—a psoriasis and rheumatoid arthritis treatment—exemplifies the company's role in supplying essential prescription medications to support federal healthcare operations.
Quick answers
Who was awarded contract SPE2DR26FJ5D5?
SPE2DR26FJ5D5 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 13, 2026.
How much is contract SPE2DR26FJ5D5 worth?
The government has obligated $13,442 on SPE2DR26FJ5D5.
Is contract SPE2DR26FJ5D5 an order under another contract?
Yes. SPE2DR26FJ5D5 is a delivery order under SPE2DR25D2009, an indefinite delivery contract.
Was contract SPE2DR26FJ5D5 competed?
The extent of competition for SPE2DR26FJ5D5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award